search Program funded by the Ministry of Science and Technolo-
gy of the Korean government.
Table 3 Inhibitory effects of the compounds 1±5 isolated form S. ja-
ponica and analogues (1a and 3a) on complement system of
classical pathway
References
Compound
IC50 (mM)
1
Kirschfink M. Controlling the complement system in inflammation.
Styraxlignolide A (1)
1a
123
> 200
> 200
65
Immunopharmacology 1997; 38: 51±62
2 Ember JA, Hugli TE. Complement factors and their receptors. Immuno-
pharmacology 1997; 38: 3±15
Styraxoside A (2)
Styraxoside B (3)
3a
3 Min BS, Gao JJ, Hattori M, Lee HK, Kim YH. Anti-complement activity
of terpenoids from the spores of Ganoderma lucidum. Planta Medica
2001; 67: 811±4
> 200
33
Egonol (4)
4 Yoshikawa K, Hirai H, Tanaka M, Arihara S. Antisweet natural pro-
ducts. XV. Structures of jegosaponins A±D from Styrax japonica Sieb.
et Zucc. Chem Pharm Bull 2000; 48: 1093±6
Masutakeside I (5)
Rosmarinic acida
166
182
5 Kitagawa I, Imakura Y, Hayashi T, Yosioka I. Structure of desacyl-jego-
saponin, a common desacyl derivative of jegosaponin isolated from
pericarps of Styrax japonica Sieb. et Zucc. Chem Pharm Bull 1974; 22:
1675±7
a This compound was used as positive control [11], [12].
6 Kitagawa I, Imakura Y, Hayashi T, Yosioka I. Saponin and sapogenol. X.
Structures of jegosapogenin and desacyljegosaponin obtained from
pericarps of Styrax japonica Sieb. et Zucc. Chem Pharm Bull 1975; 23:
1520±31
Celimisia petriei [18]. On enzymic hydrolysis, 3 yielded the
monosaccharide units D-glucuronic acid and L-rhamnose. The
configuration of the glycosidic linkage for the glucuronopyrano-
side was determined as b, on the basis of the J1,2 value of 7.4 Hz
(at d = 5.05) and of the rhamnopyranoside unit as a on the basis
of the small J1,2 value (anti-diequatorial) [19]. Sugar connectiv-
ities were resolved from correlations between dH = 5.05 (H-1¢)
and dC = 88.9 (C-3), and dH = 6.60 (H-1¢¢) and dC = 77.4 (C-2¢) in
the HMBC experiment. In view of the evidence obtained, the
structure of 3 was established as 3b,17b-dihydroxy-28-noro-
lean-12-en-16-one 3-O-[a-L-rhamnopyranoside-(1®2)-b-D-glu-
curonopyranoside].
7 Kitagawa I, Yoshikawa M, Kobayashi K, Imakura Y, Im KS, Ikenishi Y.
Saponin and sapogenol. XXVIII. Reinvestigation of the branching posi-
tions in the glucuronide moieties of three glucuronide saponins: desa-
cyl-jegosaponin, desacyl-boninsaponin A, and sakuraso-saponin.
Chem Pharm Bull 1980; 28: 296±300
8 Kwon YK, Kim SU. Phytochemical studies on seeds of Styrax japonica
Sieb. et Zucc. Agric Chem Biotechnol 2002; 45: 28±30
9 Choi HD, Ha MC, Seo PJ, Son BW, Song JC. Total synthesis of a deme-
thoxy-egonol from Styrax obassia. Arch Pharm Res 2000; 23: 438±40
Hara S, Okabe H, Mihashi K. Separation of aldose enantiomers by gas-
liquid chromatography. Chem Pharm Bull 1986; 34: 1843±5
10
11
Yamada H, Ohtani K, Kiyohara H, Cyong JC, Otsuka Y, Ueno Y, Omura S.
Purification and chemical properties of anti-complementary polysac-
charide from the leaves of Artemisia princeps. Planta Medica 1985; 51:
121 ± 5
Compounds 1±5 were tested for anti-complement activity. Com-
pounds 1, 3, 4, and 5 inhibited the hemolytic activity of the com-
plement system with IC50 values of 123, 65, 33, and 166 mM,
respectively. On the other hand, 2 was incapable of inhibiting
complement activity. The aglycones 1a and 3a, obtained from 1
and 3, were additionally evaluated for anti-complement activity.
However, compounds 1a and 3a were inactive in our assay sys-
tem. A comparison of compounds 3 (1) and 3a (1a) further con-
firmed that the sugar of the saponin is necessary to enhance the
anti-complement activity of human serum against erythrocytes.
This finding is consistent with the anti-complementary proper-
ties of kaikasaponin III and soyasaponin I from Pueraria lobata,
as well as their hydrolytic analogues [20]. The most interesting
structure-activity correlation was observed in the case of 1a, a
dimethoxy derivative of egonol (4). Of all the compounds tested,
4 was the most active, displaying an IC50 value of 33 mM. In con-
trast, 1a was completely inactive in this assay system. Our find-
ings strongly suggest that the methylenedioxy group on the nor-
lignan plays an important role in inhibiting the hemolytic activ-
ity of human serum against erythrocytes.
12
Englberger W, Hadding U, Etschenberg E, Graf E, Leyck S, Winkelmann
1215
J, Parnham MJ. Rosmarinic acid: a new inhibitor of complement C3-
convertase with anti-complementary activity. Int J Immunopharma-
col 1988; 10: 728±37
Pauletti PM, Araujo AR, Young MCM, Giesbrecht AM, Bolzani VS. nor-
Lignans from the leaves of Styrax ferrugineus (Styracaceae) with anti-
bacterial and antifungal activity. Phytochemistry 2000; 55: 597±601
Yoshikawa K, Bando S, Arihara S, Matsumura E, Katayama S. A benzo-
furan glycoside and an acetylenic acid from the fungus Laetiporus
sulphureus var. miniatus. Chem Pharm Bull 2001; 49: 327±9
Sakai T, Nakagawa Y. Diterpenic stress metabolites from cassava roots.
13
14
15
Phytochemistry 1988; 27: 3769±79
Provan G, Waterman PG. The mansumbinanes: octanordammaranes
from the resin of Commiphora incisa. Phytochemistry 1986; 25: 917±
22
16
17
Yoshikawa M, Morikawa T, Fujiwara E, Ohgushi T, Asao Y, Matsuda H.
New noroleanane-type triterpene saponins with gastroprotective ef-
fect and platelet aggregation activity from the flowers of Camellia
japonica: related structures of camellenodiol and camelledionol. Het-
erocycles 2001; 55: 1653±7
Rowan D, Newman RH. Noroleanane saponins from Celmisia petriei.
Phytochemistry 1984; 23: 639±44
18
19
Min BS, Tomiyama M, Ma CM, Nakamura N, Hattori M. Kaempferol
acetylrhamnosides from the rhizome of Dryopteris crassirhizoma and
their inhibitory effects on three different activities of human immuno-
deficiency virus-1 reverse transcriptase. Chem Pharm Bull 2001; 49:
546±50
Acknowledgements
20 Oh SR, Kinjo J, Shii Y, Ikeda T, Nohara T, Ahn KS, Kim JH, Lee HK. Effects
of triterpenoids from Pueraria lobata on immunohemolysis: b-D-glu-
curonic acid plays an active role in anticomplementary activity in vi-
tro. Planta Medica 2000; 66: 506±10
This research was supported by a grant (PF0300401-00) from the
Plant Diversity Research Center of the 21st Century Frontier Re-
Min B-S et al. Anti-Complement Activity of¼ Planta Med 2004; 70: 1210±1215